# Spirometry Market

> Spirometry Market Research Report Information By Product (Tabletop Spirometry, Hand-held Spirometry, and Desktop Spirometry), By Technology (PFM, Volume Measurement Spirometry, and Flow Measurement Spirometry), By Application (Diagnostic and Treatment Monitoring), By End Users (Hospitals & Clinics, Home Care, Diagnostic Centers, and Research & Academic Institutes), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 10.9%
- **2024:** $ 0.67 Billion
- **2025:** $ 0.74 Billion
- **2035:** $ 2.08 Billion
- **Key Players:** Philips (NL), Fujifilm (JP), CareFusion (US), MediSoft (FR), Schiller (CH), NDD Medical Technologies (CH), Vitalograph (IE), Cosmed (IT), Boehringer Ingelheim (DE)

**Report ID:** MRFR/MED/5077-CR · **Pages:** 120 · **Author:** Rahul Gotadki & Kinjoll Dey · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/spirometry-market-6539

---

## Market Summary

## **Global Spirometry Market Overview**

Spirometry Market Size was valued at USD 0.5 billion in 2022 and is projected to grow from USD 0.6 Billion in 2023 to USD 1.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9% during the forecast period (2023 - 2030). 

The market is anticipated to be driven by an increase in the prevalence of chronic respiratory disorders, rising demand for home healthcare, and technological advances.

****

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **Cervical Fusion Market Trends**

To assess the fundamental operation of the lungs, lung function tests are important. Physicians can diagnose various lung illnesses, including COPD, by evaluating PFTs, which measure lung volumes, lung capacities, rates of flow, and gas exchange. On the market, technological advancements are anticipated to have a significant impact. Early diagnosis of COPD is anticipated to be made possible by significant expenditures made by the major market participants in the substantial research and development of novel and cutting-edge diagnostic and monitoring technologies.

The underutilization of pulmonary function testing has been addressed by creating portable, hand-held, and user-friendly spirometry devices. For instance, the U.S. FDA approved NuvoAir's linked spirometer for nationwide sales in January 2020. The system treats conditions like [cystic fibrosis](../../../reports/cystic-fibrosis-market-1825), asthma, and COPD. Thus, one of the market-driving growth elements is ongoing innovation.

The third biggest cause of death globally, COPD places a heavy burden on patients and healthcare systems. According to the National Heart, Lung, and Blood Institute, COPD, which affects about 16 million Americans, is the main cause of death in the country. Smoking is a significant risk factor for COPD. Yet, other environmental exposures like exposure to biomass fuels and air pollution may also harm your health.

## **Spirometry Market Segment Insights**

### **Spirometry Product Insights**

Based on product, the global spirometry market segmentation includes tabletop spirometry, hand-held spirometry, and desktop spirometry. The tabletop category dominated the global spirometry market with a 43.6% revenue share in 2022. Due to its widespread use in treating respiratory illnesses like asthma and COPD, and other pulmonary diseases, the market is anticipated to expand quickly. Due to their portability and ability to save hundreds of diagnostic test findings and print them on a normal printer, portable spirometers have grown in popularity. Moreover, outcomes can be uploaded to patients' electronic medical records and flash drives (EMRs).

By expanding pulmonary function testing outside of the laboratory and into primary care settings, hand-held portable spirometers have made it possible to identify lung blockages early and start therapy.

On the other hand, desktop spirometers are anticipated to expand at the quickest rate throughout the projection period, with a compound annual growth rate (CAGR) of 10.53%. This is because they offer integrated clinical information for better clinical judgments. They could lighten the load of paperwork. Also, practitioners can assess pulmonary congestion or restriction thanks to instant access to patient records via the computer.

### **Spirometry Technology Insights**

Based on technology, the global spirometry market segmentation includes PFM, volume measurement spirometry, and flow measurement spirometry. In 2022, the flow measurement category held the largest market share, with 66.7% of the total. This is because it has numerous uses in pulmonary function tests. They are simpler to handle because they typically use tabletop technology and don't have any moving parts. Spirometers for flow measurement are very simple to automate due to their comparative superior frequency characteristics. They also offer a graphic examination of the flow produced by the technique. Flow spirometers monitor both inspiration and expiration.

These gadgets are preferred in workplace and healthcare environments.

The market segment for peak flow measurement is anticipated to develop at the fastest rate during the projected period. Peak flow measurement tools can alert users before an asthma attack by displaying signs of bronchial airway contraction. As a result, asthma patients can receive medical attention when they need it. Peak flow and FEV1 measurements can be recorded at home using mobile applications like Smart One, and the findings can be electronically transmitted to the doctor.

### **Spirometry Application Insights**

The global spirometry market data has been bifurcated by application into diagnostic and treatment monitoring. In 2022, the diagnostic segment had the largest segment share. The high and increasing prevalence of COPD worldwide and the simplicity of spirometry-based COPD diagnosis are two factors that contribute to the substantial proportion of this market. Contrarily, the segment for treatment monitoring is anticipated to develop at the quickest rate throughout the projection period. This results from the increased prevalence of asthma in adults and children.

Over 14% of children worldwide have asthma, and the yearly expenditures for treating asthma in the U.S. are nearly USD 18 billion.

**Figure 2: Spirometry Market, by Application, 2022 & 2030 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **Spirometry End User Insights**

Based on End Users, the global spirometry industry has been segmented into hospitals & clinics, home care, diagnostic centers, and research & academic institutes. Throughout the forecast period, the hospitals & clinics segment is anticipated to hold a significant market share. The dominance resulted from rising healthcare costs that encouraged using sophisticated pulmonary function testing equipment. For instance, Ruby Hall in Pune, India, declared the installation of the pulmonary function test device in August 2019. According to the hospital, the device aids in producing an accurate test for lung disease.

Because more patients are choosing to have their lung function tests at the nearest diagnostic center, the diagnostic centers are anticipated to experience the fastest CAGR growth. Due to the centers' increased use of mobile devices, sales have increased.

### **Spirometry Regional Insights**

By Region, the study provides market insights into North America, Europe, Asia-Pacific and Rest of the World. The fact that North America held the largest market share in 2022 (41.8%) was mostly caused by the rising incidence of respiratory disorders. Spirometers, which aid in disease control and are frequently used by doctors in hospitals, have become more popular due to the rise in occurrences of asthma and COPD. The United States has also been noted as an early adopter of technologies that helps lower COPD rates. Due to those above, the market is anticipated to expand throughout the forecast period.

Further, the major countries studied in the market report are The U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 3: SPIROMETRY MARKET SHARE BY REGION 2022 (%)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

Europe's spirometry market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, an aging population, and an increase in the incidence of COPD and asthma disorders. Further, the German spirometry market held the largest market share, and the U.K. spirometry market was the fastest-growing market in the European Region.

The Asia-Pacific Spirometry Market is expected to grow at the fastest CAGR from 2023 to 2030. The Asia Pacific market is anticipated to be driven by improvements in primary care activities for the early detection and management of chronic lung illnesses, including COPD and asthma, over the forecasted period. Moreover, China's spirometry market held the largest market share, and the Indian spirometry market was the fastest-growing market in the Asia-Pacific region.

**Cervical Fusion Key Market Players & Competitive Insights**

Leading industry players are investing a lot of money in R&D to expand their product offerings, which will spur further market growth for spirometry. With significant industry changes like new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations, market participants are also undertaking various strategic activities to expand their global presence. Spirometry sector competitors must provide affordable products to grow and survive in a more cutthroat and competitive market climate.

Manufacturing locally to cut operating costs is one of the main business tactics manufacturers use in the global spirometry industry to benefit customers and develop the market sector. The spirometry market major player such as NDD Medical Technologies Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), and others are working on expanding the market demand by investing in research and development activities.

Schiller AG (Switzerland) is a top producer and supplier of software solutions for the medical sector and devices for cardiopulmonary diagnostics, defibrillation, and patient monitoring. Schiller has dedicated more than 40 years to the struggle against sudden cardiac death. In 2018, Schiller AG opened a new manufacturing site in Guangzhou, China.

Also, Tactio Health Group (Canada) is a world leader in mobile health systems, with millions using its mobile health applications on iOS and Android, enjoying the personal and family benefits of being led to live a more active, healthier lifestyle. In 2017, MIR partnered with Tactio Health Group to develop telemedicine solutions for COPD.

**Key Companies in the spirometry market include**

### Spirometry Market Industry Developments

- **Q2 2024: Vyaire Medical Announces Launch of New AioCare Mobile Spirometry System** Vyaire Medical launched its new AioCare mobile spirometry system, designed to provide real-time lung function testing and remote patient monitoring, expanding its digital respiratory care portfolio.
- **Q1 2024: MGC Diagnostics Launches Ultima PFX Platinum Series Spirometry System** MGC Diagnostics introduced the Ultima PFX Platinum Series, a next-generation spirometry and pulmonary function testing system, featuring enhanced connectivity and improved patient comfort.
- **Q2 2024: ndd Medical Technologies Receives FDA 510(k) Clearance for EasyOne Air Pro Spirometer** ndd Medical Technologies received FDA 510(k) clearance for its EasyOne Air Pro spirometer, enabling expanded use in clinical and home settings for lung function assessment.
- **Q3 2024: Vitalograph Announces Partnership with Medtronic to Integrate Spirometry into Remote Patient Monitoring Platform** Vitalograph entered a partnership with Medtronic to integrate its spirometry devices into Medtronic's remote patient monitoring platform, aiming to enhance respiratory care for chronic disease patients.
- **Q2 2024: Hillrom Launches New Portable Spirometer for Primary Care Settings** Hillrom launched a new portable spirometer designed for use in primary care clinics, featuring wireless connectivity and simplified workflows for faster lung function testing.
- **Q1 2024: COSMED Unveils Q-Box 2, an Advanced Body Plethysmograph and Spirometry System** COSMED launched the Q-Box 2, a new body plethysmograph and spirometry system, offering advanced lung volume measurement and improved patient experience.
- **Q2 2024: Midmark Corporation Introduces New Spirometry Module for Digital Diagnostic Platform** Midmark Corporation introduced a new spirometry module for its digital diagnostic platform, enabling seamless integration of lung function testing into electronic health records.
- **Q3 2024: NDD Medical Technologies Expands Manufacturing Facility in Andover, Massachusetts** NDD Medical Technologies expanded its manufacturing facility in Andover, Massachusetts, to increase production capacity for its spirometry and pulmonary function testing devices.
- **Q2 2024: Vitalograph Launches In2itive Pro, a New Handheld Spirometer for Clinical Trials** Vitalograph launched the In2itive Pro, a new handheld spirometer designed specifically for use in clinical trials, offering enhanced data security and compliance features.
- **Q1 2024: Teleflex Acquires PulmoTech, Expanding Respiratory Diagnostics Portfolio** Teleflex acquired PulmoTech, a company specializing in spirometry and respiratory diagnostics, to broaden its product offerings in the respiratory care market.
- **Q2 2024: Smiths Medical Receives CE Mark for New SpiroPro Digital Spirometer** Smiths Medical received CE Mark approval for its SpiroPro digital spirometer, allowing commercialization in the European Union and expanding its global respiratory diagnostics portfolio.
- **Q3 2024: KoKo, LLC Announces Strategic Partnership with Philips for Spirometry Integration** KoKo, LLC entered a strategic partnership with Philips to integrate its spirometry technology into Philips' connected health solutions, aiming to improve respiratory disease management.

## **Spirometry Market Segmentation**

### **Spirometry Product Outlook**

### **Spirometry Technology Outlook**

### **Spirometry Application Outlook**

### **Spirometry End User Outlook**

### **Cervical Fusion Regional Outlook**

## Market Drivers

### Regulatory Support and Guidelines

Regulatory support and the establishment of guidelines for respiratory health are pivotal drivers for the Spirometry Market. Various health authorities are advocating for the use of spirometry in clinical practice, which is likely to enhance its adoption among healthcare providers. These guidelines often emphasize the importance of regular lung function testing, particularly for high-risk populations. As regulatory bodies continue to promote best practices in respiratory care, the demand for spirometry devices is expected to grow. Furthermore, compliance with these regulations may encourage healthcare facilities to invest in spirometry technology, thereby expanding the market. The alignment of regulatory frameworks with clinical needs is crucial for fostering innovation and ensuring the availability of high-quality spirometry devices.

### Growing Awareness of Respiratory Health

The increasing awareness of respiratory health among the general population is a significant driver for the Spirometry Market. Educational campaigns and public health initiatives are playing a crucial role in informing individuals about the importance of lung function testing. As more people recognize the impact of respiratory diseases on quality of life, there is a growing demand for spirometry testing as a preventive measure. Market data indicates that awareness programs are leading to higher rates of screening and diagnosis, which in turn drives the need for spirometry devices. This heightened awareness not only encourages individuals to seek testing but also motivates healthcare providers to incorporate spirometry into routine assessments, thereby expanding its utilization in various healthcare settings.

### Increased Focus on Preventive Healthcare

The growing emphasis on preventive healthcare is shaping the Spirometry Market. As healthcare systems worldwide shift towards proactive management of health conditions, spirometry is increasingly recognized as a vital tool for early detection of respiratory issues. This trend is supported by initiatives aimed at promoting lung health and reducing the burden of respiratory diseases. Data indicates that healthcare expenditures on preventive measures are rising, which is likely to enhance the adoption of spirometry in routine health assessments. By integrating spirometry into preventive care protocols, healthcare providers can identify at-risk individuals earlier, leading to timely interventions and improved health outcomes. This shift not only benefits patients but also aligns with broader public health goals.

### Rising Prevalence of Respiratory Diseases

The increasing incidence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) is a primary driver for the Spirometry Market. According to recent data, respiratory diseases affect millions of individuals worldwide, leading to a heightened demand for diagnostic tools like [spirometers](https://www.marketresearchfuture.com/reports/spirometer-market-43511). The World Health Organization indicates that respiratory diseases are among the leading causes of morbidity and mortality, which underscores the necessity for effective monitoring and management. As healthcare providers seek to improve patient outcomes, the adoption of spirometry as a standard diagnostic tool is likely to expand. This trend not only reflects the growing awareness of respiratory health but also emphasizes the critical role of spirometry in early detection and ongoing management of these conditions.

### Technological Innovations in Spirometry Devices

Technological advancements in spirometry devices are significantly influencing the Spirometry Market. Innovations such as portable spirometers, smartphone integration, and cloud-based data management systems are enhancing the usability and accessibility of these devices. The introduction of advanced features, including real-time data analysis and remote monitoring capabilities, is likely to attract both healthcare professionals and patients. Market data suggests that the demand for user-friendly and efficient spirometry devices is on the rise, as they facilitate better patient engagement and adherence to treatment plans. Furthermore, these innovations are expected to drive competition among manufacturers, leading to improved product offerings and potentially lower prices, thereby expanding the market reach.

## Future Outlook

The Spirometry Market is projected to grow at a 10.9% CAGR from 2025 to 2035, driven by technological advancements, increasing respiratory diseases, and rising awareness of lung health.

**New opportunities:**

- Development of portable spirometry devices for home use Integration of AI for enhanced diagnostic capabilities Expansion into emerging markets with tailored solutions

By 2035, the Spirometry Market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Product: Tabletop Spirometry (Largest) vs. Hand-held Spirometry (Fastest-Growing)

In the Spirometry Market, the distribution of market share among the product segments reveals that Tabletop Spirometry holds the largest share due to its widespread adoption in clinical settings. Its accuracy and reliability make it the preferred choice for healthcare professionals. In contrast, Hand-held Spirometry is gaining momentum, appealing to both patients and healthcare providers who value convenience and portability. This segment's increase in popularity highlights the evolving needs of consumers seeking at-home health management solutions. Growth trends in the Spirometry Market indicate a strong upward trajectory for Hand-held Spirometry, driven by advances in technology and the growing emphasis on home healthcare. Factors such as an aging population, rising respiratory diseases, and increased awareness of lung health significantly contribute to this segment's expansion. Additionally, the integration of digital technologies in handheld devices is enhancing their functionality and attracting investment, further boosting market growth.

Tabletop Spirometry (Dominant) vs. Hand-held Spirometry (Emerging)

Tabletop Spirometry is characterized by its robust design and high-tech capabilities, providing precise measurements of lung function in clinical environments. This segment is widely accepted in hospitals and medical facilities due to its reliability and comprehensive data analysis, allowing healthcare professionals to make informed decisions. On the other hand, Hand-held Spirometry, while considered an emerging segment, focuses on mobility and user-friendly interfaces. It is increasingly favored for personal monitoring and is designed for ease of use, making it suitable for patients outside traditional medical settings. The synergy of these segments demonstrates an adaptable market catering to varying consumer needs, from professional healthcare delivery to personal health management.

### By Technology: PFM (Largest) vs. Flow Measurement Spirometry (Fastest-Growing)

The Technology segment of the Spirometry Market showcases a diverse distribution of market share among its prominent values. Peak Flow Monitoring (PFM) stands out as the largest segment, highlighting a consistent demand driven by its accuracy and simplicity in asthma management. Following closely, Flow Measurement Spirometry is emerging as the fastest-growing segment, attributed to advancements in technology that enhance diagnostic precision and patient monitoring capabilities in various clinical settings. The Volume Measurement Spirometry segment also contributes significantly, but it trails behind the leading technologies in terms of market presence.

Technology: PFM (Dominant) vs. Flow Measurement Spirometry (Emerging)

PFM technology dominates the Spirometry Market due to its established use in routine asthma checks and its ability to deliver quick and reliable results. This segment appeals to both healthcare providers and patients, thanks to its straightforward operation and cost effectiveness. In contrast, Flow Measurement Spirometry is recognized as an emerging segment characterized by high-tech features that improve diagnostic accuracy and enhance patient care. As healthcare providers increasingly adopt advanced diagnostic tools, Flow Measurement Spirometry is experiencing rapid growth, making it an attractive area for investment and innovation in the spirometry landscape.

### By Application: Diagnostic (Largest) vs. Treatment Monitoring (Fastest-Growing)

In the Spirometry Market, the 'Diagnostic' segment continues to dominate the application landscape, holding a significant market share compared to the 'Treatment Monitoring' segment. This prevalence is primarily driven by the increasing prevalence of respiratory diseases and a growing emphasis on early diagnosis and prevention. The comprehensive utilization of spirometry devices for diagnosing conditions such as asthma and chronic obstructive pulmonary disease (COPD) positions this segment as the largest contributor within the market.

Application: Diagnostic (Dominant) vs. Treatment Monitoring (Emerging)

The Diagnostic segment is characterized by its pivotal role in early detection and management of respiratory conditions, fostering better patient outcomes. This segment benefits from extensive adoption in clinical settings, supported by health policies emphasizing systematic screening. Conversely, the Treatment Monitoring segment is emerging rapidly, driven by advancements in technology and a shift towards value-based healthcare. While it currently holds a smaller market share, its growth is fueled by increased patient engagement and the adoption of digital health solutions that enable continuous monitoring and personalized treatment plans. These contrasting segment values highlight the evolving dynamics in the Spirometry Market.

### By End User: Hospitals & Clinics (Largest) vs. Home Care (Fastest-Growing)

The Spirometry Market is primarily dominated by Hospitals & Clinics, which account for a substantial portion of the market share. These facilities play a crucial role in diagnosing respiratory conditions, utilizing advanced spirometry equipment to provide accurate assessments for patients. In recent years, Diagnostic Centers and Research & Academic Institutes have also carved out significant shares, driven by advancements in technology and increased awareness of respiratory diseases.

Hospitals & Clinics (Dominant) vs. Home Care (Emerging)

Hospitals & Clinics are pivotal in the Spirometry Market, leveraging state-of-the-art technology to deliver precise pulmonary function tests. This segment remains dominant due to the high volume of patients requiring extensive respiratory treatments and diagnostics. Conversely, Home Care is emerging as a significant player, driven by the demand for convenience and the increasing prevalence of chronic respiratory diseases. Patients favor home monitoring devices for their ability to provide real-time data and routine management without the need for frequent hospital visits. As technology progresses, the Home Care segment is expected to witness rapid growth, complementing traditional healthcare settings.

## Regional Market Share Analysis

By Region, the study provides market insights into North America, Europe, Asia-Pacific and Rest of the World. The fact that North America held the largest market share in 2022 (41.8%) was mostly caused by the rising incidence of respiratory disorders. Spirometers, which aid in disease control and are frequently used by doctors in hospitals, have become more popular due to the rise in occurrences of asthma and COPD. The United States has also been noted as an early adopter of technologies that helps lower COPD rates. Due to those above, the market is anticipated to expand throughout the forecast period.

Further, the major countries studied in the market report are The U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Europe's spirometry market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, an aging population, and an increase in the incidence of COPD and asthma disorders. Further, the German spirometry market held the largest market share, and the U.K. spirometry market was the fastest-growing market in the European Region.

The Asia-Pacific Spirometry Market is expected to grow at the fastest CAGR from 2023 to 2030. The Asia Pacific market is anticipated to be driven by improvements in primary care activities for the early detection and management of chronic lung illnesses, including COPD and asthma, over the forecasted period. Moreover, China's spirometry market held the largest market share, and the Indian spirometry market was the fastest-growing market in the Asia-Pacific region.

## Competitive Benchmarking

Leading industry players are investing a lot of money in R&D to expand their product offerings, which will spur further market growth for spirometry. With significant industry changes like new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations, market participants are also undertaking various strategic activities to expand their global presence. Spirometry Market sector competitors must provide affordable products to grow and survive in a more cutthroat and competitive market climate.Manufacturing locally to cut operating costs is one of the main business tactics manufacturers use in the global spirometry industry to benefit customers and develop the market sector. The spirometry market major player such as NDD Medical Technologies Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), and others are working on expanding the market demand by investing in research and development activities.Schiller AG (Switzerland) is a top producer and supplier of software solutions for the medical sector and devices for cardiopulmonary diagnostics, defibrillation, and patient monitoring. Schiller has dedicated more than 40 years to the struggle against sudden cardiac death. In 2018, Schiller AG opened a new manufacturing site in Guangzhou, China.Also, Tactio Health Group (Canada) is a world leader in [mobile health](https://www.marketresearchfuture.com/reports/mobile-health-market-1816) systems, with millions using its mobile health applications on iOS and Android, enjoying the personal and family benefits of being led to live a more active, healthier lifestyle. In 2017, MIR partnered with Tactio Health Group to develop telemedicine solutions for COPD.

## Recent News & Developments

- **Q2 2024: Vyaire Medical Announces Launch of New AioCare Mobile Spirometry Market System** Vyaire Medical launched its new AioCare mobile spirometry system, designed to provide real-time lung function testing and remote patient monitoring, expanding its digital respiratory care portfolio.
- **Q1 2024: MGC Diagnostics Launches Ultima PFX Platinum Series Spirometry Market System** MGC Diagnostics introduced the Ultima PFX Platinum Series, a next-generation spirometry and pulmonary function testing system, featuring enhanced connectivity and improved patient comfort.
- **Q2 2024: ndd Medical Technologies Receives FDA 510(k) Clearance for EasyOne Air Pro Spirometer** ndd Medical Technologies received FDA 510(k) clearance for its EasyOne Air Pro spirometer, enabling expanded use in clinical and home settings for lung function assessment.
- **Q3 2024: Vitalograph Announces Partnership with Medtronic to Integrate Spirometry Market into Remote Patient Monitoring Platform** Vitalograph entered a partnership with Medtronic to integrate its spirometry devices into Medtronic's remote patient monitoring platform, aiming to enhance respiratory care for chronic disease patients.
- **Q2 2024: Hillrom Launches New Portable Spirometer for Primary Care Settings** Hillrom launched a new portable spirometer designed for use in primary care clinics, featuring wireless connectivity and simplified workflows for faster lung function testing.
- **Q1 2024: COSMED Unveils Q-Box 2, an Advanced Body Plethysmograph and Spirometry Market System** COSMED launched the Q-Box 2, a new body plethysmograph and spirometry system, offering advanced lung volume measurement and improved patient experience.
- **Q2 2024: Midmark Corporation Introduces New Spirometry Market Module for Digital Diagnostic Platform** Midmark Corporation introduced a new spirometry module for its digital diagnostic platform, enabling seamless integration of lung function testing into [electronic health records](https://www.marketresearchfuture.com/reports/electronic-health-records-market-66597).
- **Q3 2024: NDD Medical Technologies Expands Manufacturing Facility in Andover, Massachusetts** NDD Medical Technologies expanded its manufacturing facility in Andover, Massachusetts, to increase production capacity for its spirometry and pulmonary function testing devices.
- **Q2 2024: Vitalograph Launches In2itive Pro, a New Handheld Spirometer for [Clinical Trials](https://www.marketresearchfuture.com/reports/clinical-trials-market-7787)** Vitalograph launched the In2itive Pro, a new handheld spirometer designed specifically for use in clinical trials, offering enhanced data security and compliance features.
- **Q1 2024: Teleflex Acquires PulmoTech, Expanding Respiratory Diagnostics Portfolio** Teleflex acquired PulmoTech, a company specializing in spirometry and respiratory diagnostics, to broaden its product offerings in the respiratory care market.
- **Q2 2024: Smiths Medical Receives CE Mark for New SpiroPro Digital Spirometer** Smiths Medical received CE Mark approval for its SpiroPro digital spirometer, allowing commercialization in the European Union and expanding its global respiratory diagnostics portfolio.
- **Q3 2024: KoKo, LLC Announces Strategic Partnership with Philips for Spirometry Market Integration** KoKo, LLC entered a strategic partnership with Philips to integrate its spirometry technology into Philips' connected health solutions, aiming to improve respiratory disease management.

## Report Scope

| MARKET SIZE 2024 | 0.6654(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 0.7379(USD Billion) |
| MARKET SIZE 2035 | 2.076(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.9% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Philips (NL), Fujifilm (JP), CareFusion (US), MediSoft (FR), Schiller (CH), NDD Medical Technologies (CH), Vitalograph (IE), Cosmed (IT), Boehringer Ingelheim (DE) |
| Segments Covered | Product, Technology, Application, End Users, Region |
| Key Market Opportunities | Integration of artificial intelligence in Spirometry Market enhances diagnostic accuracy and patient management. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Spirometry Market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Spirometry Market by 2035?**
A: The Spirometry Market is projected to reach a valuation of 2.076 USD Billion by 2035.

**Q: What was the market valuation of the Spirometry Market in 2024?**
A: In 2024, the Spirometry Market had a valuation of 0.6654 USD Billion.

**Q: What is the expected CAGR for the Spirometry Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Spirometry Market during the forecast period 2025 - 2035 is 10.9%.

**Q: Which product segment is anticipated to have the highest valuation in the Spirometry Market?**
A: The Tabletop Spirometry segment is anticipated to have the highest valuation, projected to grow from 0.2664 to 0.8005 USD Billion.

**Q: What are the key applications driving growth in the Spirometry Market?**
A: The key applications driving growth include Diagnostic and Treatment Monitoring, with Diagnostic projected to grow from 0.3998 to 1.2276 USD Billion.

**Q: Which end-user segment is expected to dominate the Spirometry Market?**
A: The Hospitals & Clinics segment is expected to dominate, with a projected growth from 0.2662 to 0.8264 USD Billion.

**Q: Who are the leading players in the Spirometry Market?**
A: Key players in the Spirometry Market include Philips, Fujifilm, CareFusion, and Boehringer Ingelheim.

**Q: What technology segments are contributing to the Spirometry Market's growth?**
A: Technology segments such as Volume Measurement Spirometry and Flow Measurement Spirometry are contributing, with Volume Measurement projected to grow from 0.2668 to 0.853 USD Billion.

**Q: How does the Home Care segment compare to other end-user segments in the Spirometry Market?**
A: The Home Care segment is projected to grow from 0.1331 to 0.3992 USD Billion, indicating a notable increase but still less than Hospitals & Clinics.

**Q: What trends are influencing the Spirometry Market's growth trajectory?**
A: Trends such as increasing demand for home care solutions and advancements in spirometry technology are influencing the market's growth trajectory.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/spirometry-market-6539*